A Phase I Study of Sequential Vaccinations With Fowlpox-CEA(6D)-TRICOM (B7.1/ICAM/LFA-3) Alone, and in Combination With Vaccinia-CEA(6D)-TRICOM, and the Role of GM-CSF, in Patients With CEA Expressing Carcinomas
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cancer vaccine (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 16 May 2013 Biomarkers information updated
- 15 May 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 20 Apr 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.